Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-28T02:30:31.385Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroleptic Malignant Syndrome and Diabetic Keto-acidosis

Published online by Cambridge University Press:  02 January 2018

C. de Boer  and
H. P. Gaete
C. de Boer*
Affiliation:
The Princess Royal Hospital, West Wing, Colwell Road, Haywards Heath, Sussex RH16 4EZ
H. P. Gaete
Affiliation:
The Princess Royal Hospital, West Wing, Colwell Road, Haywards Heath, Sussex RH16 4EZ
*
∗Senior Registrar in Child and Adolescent Psychiatry, Westcotes House, Westcotes Drive, Leicester LE3 0QU
Get access Rights & Permissions [Opens in a new window]

Abstract

A patient suffering from schizophrenia developed diabetic keto-acidosis and NMS after treatment with neuroleptics. The combination of two uncommon complications of treatment with neuroleptics proved fatal.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 161 , Issue 6 , December 1992 , pp. 856 - 858
Copyright
Copyright © 1992 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Addonizio, G., Susman, V. L. & Roth, S. D. (1986) Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. American Journal of Psychiatry, 143, 1587–1589.Google ScholarPubMed
Adityanjee, , Sing, S., Singh, G., et al (1988) Spectrum concept of neuroleptic malignant syndrome. British Journal of Psychiatry, 153, 107–111.Google Scholar
Baldessarini, R. J. (1980) Drugs and the treatment of psychiatric disorders. In Goodman & Gilman's The Pharmacological Basis of Therapeutics (eds A. Goodman Gilman, L. S. Goodman & A. Gilman), p. 403. New York: MacMillan.Google Scholar
Keck, P. E., McElroy, S. L. & Pope, H. G. (1991) Neuroleptic malignant syndrome. Current Opinion in Psychiatry, 4, 34–37.Google Scholar
Kellam, A. M. P. (1990) The (frequently) neuroleptic (potentially) malignant syndrome. British Journal of Psychiatry, 157, 169–173.Google Scholar
Levenson, J. L. (1985) Neuroleptic malignant syndrome. American Journal of Psychiatry, 142, 1137–1145.Google Scholar
Rosebush, P. & Stewart, T. (1989) A prospective analysis of 24 episodes of neuroleptic malignant syndrome. American Journal of Psychiatry, 146, 717–725.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.